New solutions are proliferating to improve the efficiency
of the clinical research function within pharmaceutical
companies and CROs. In her article, Theodora Sarver of
Almac reviews the challenges that sites and sponsors/
CROs face in complying with good practices and explains
how accountability can be improved to reduce trial
risks and all but eliminate the dreaded reconciliation
process.